Valentine Delabie, Author at BioFIT

Introducing Ceva as a Silver Sponsor of BioFIT 2024!

We are delighted to welcome Ceva Santé Animale as a Silver Sponsor of BioFIT 2024.

Ceva, a leading global player in animal health, is an independent French company at the forefront of innovation in France, Europe and worldwide. Ceva is dedicated to advancing animal health solutions, from cutting-edge vaccines to revolutionary biotech and pharmaceuticals applications.

Ceva’s mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being, driven by the #OneHealth approach – the understanding that the health of people, animals and the planet are interconnected. Ceva’s comprehensive product range includes health solutions for numerous animal species (both farm and companion animals), as well as equipment, training, technical support and smart services.

Ceva is pioneer in preventive health, investing 54% of its R&D budget into developing preventive solutions, including groundbreaking work in mRNA vaccine technology. With over 25 years of experience, Ceva is also globally recognized for its pharmaceutical expertise, particularly in small-molecules development for complex diseases such as cardiophatologies or behavior disorders.

Discover our Animal Health activities at BioFIT through key activities such as:

BioFIT’s Animal Health highlights conferences
- Investors and Animal Health: Expectations and perspectives for 2025, on December 3^rd, from 2.00 to 2.45 pm
- The Ageing of Man and Animal: crafting longer, happier and healthier lives for an ageing population of Pets and People through collaborative translational approaches, from 3.00 to 3.30 pm
Animal Health Presentation, a pitch competition for innovations related to Animal Health, co-organised by the SIMV (Syndicate of the Veterinary Medicines and diagnostics Industry) on December 3^rd, from 4.15 to 5.00 pm.

We sincerely thank Ceva for their invaluable support as a first-time sponsor of BioFIT 2024, and we look forward to witnessing their contribution to fostering synergistic innovations between animal and human health.

Introducing Ceva as a Silver Sponsor of BioFIT 2024! Read More »

We are thrilled to have Boehringer Ingelheim join us again as sponsors!

News / Valentine Delabie

For more than a century, Boehringer Ingelheim, together with its partners, has been transforming the lives of people and animals.

In 2023, the company generated €25.6 billion in global sales, reaching a record 61 million patients, and many more millions of animals, with its treatments and preventive therapies. Boehringer also invests heavily in future innovation, with an industry-leading research and development spend of €5.8 billion, or 23% of sales, to discover and develop the next generation of pioneering therapeutics.

Supporting this innovation ambition is Boehringer’s global community of partners that brings valued new ideas and new science and complements the company’s internal R&D skills and expertise. These collaborations are rooted in scientific excellence and a shared passion to address unmet needs in human and animal health.

Boehringer has learned over the generations that the challenging path towards health innovation requires long-term commitment, resilience, and transformative action. Their goal is to improve the health and lives of humans and animals – a goal that inspires the company’s 53,500 employees, across a global network of over 130 markets, to make a real and significant contribution to the health of humans and animals alike.

“BioFIT is an important event in our annual partnering calendar. It’s one of the few opportunities where we can meet partners in both human and animal health. We look forward to taking part once again and to get inspired by the latest science and the potential this offers for patients.”

Julie Edwards, Director of Alliance Management
Hervé Poulet, Director of Strategic Partnering

See the Boehringer Ingelheim team in action at BioFIT:

Tuesday December 3^rd, 4.15 – 6.00 pm

Hervé Poulet, Director Strategic Partnering, Animal Health is a member of the judging panel for the Animal Health Innovation presentations.

Wednesday December 4^th, 2.00 – 3.00 pm

Julie Edwards, Director of Alliance Management, is taking part in the discussion on: A tale of academia-pharma collaborations: What does the story teach us?

We are very pleased to welcome them to this 13^th edition of BioFIT.

We are thrilled to have Boehringer Ingelheim join us again as sponsors! Read More »

We are delighted to welcome once again Zoetis as one of our Animal Health sponsors!

News / Valentine Delabie

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners.

The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries.

In everything Zoetis does, they are guided by science and inspired by their shared love of animals. They truly believe that through this fusion of passion and research, we can accomplish anything.

Oliver Boucher, Vice President, Business Development & Strategic Alliances, said

“BioFIT is a key conference that bridges human and animal health innovation, and we are excited to support it again in 2024. At Zoetis, we embrace a One Health approach to innovation, recognising the synergies between animal and human health research. By leveraging technologies across these industries, we aim to benefit both animals and their caretakers. We are committed to fostering successful collaborations and being the partner of choice for innovators worldwide.”

It is a real honour to welcome Zoetis as one of our Animal Health sponsors for the 3^rd year! Their support of the Animal Health Presentations and Animal Health Highlights conference track only further legitimises the importance of these activities at BioFIT.

Discover our Animal Health activities at BioFIT through key activities such as:

BioFIT’s Animal Health highlights conferences
- Investors and Animal Health: Expectations and perspectives for 2025, on December 3^rd, from 2.00 to 2.45 pm
- The Ageing of Man and Animal: crafting longer, happier and healthier lives for an ageing population of Pets and People through collaborative translational approaches, sponsored by Zoetis, from 3.00 to 3.30 pm
Animal Health Presentation, a pitch competition for innovations related to Animal Health, co-organised by the SIMV (Syndicate of the Veterinary Medicines and diagnostics Industry) on December 3^rd, from 4.15 to 5.00 pm.

We are delighted to welcome once again Zoetis as one of our Animal Health sponsors! Read More »

Pfizer, Silver Sponsor of BioFIT 2024

News / Valentine Delabie

We are delighted to welcome Pfizer as a Silver Sponsor of BioFIT 2024

“At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us.“

Join key BioFIT 2024 sponsors such as Zoetis, Boehringer Ingelheim, Ceva Animal Health, GENFIT, Pfizer, Spartners, X’Prochem, and many more,to have the opportunity to:

Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
Highlight your interest in early-stage innovation
Present your ideas and technologies to key innovation players in Life Sciences
Enhance your visibility on an international scale and be recognised as a key innovative actor
Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Pfizer, Silver Sponsor of BioFIT 2024 Read More »

Innobiochips, new sponsor of BioFIT and MedFIT 2024

News / Valentine Delabie

Improved diagnostic solutions contribute to the development of more precise and personalised medicine and improve the quality of life for patients worldwide. Founded in 2008, Innobiochips provides novel, breakthrough technologies and solutions to improve the accuracy, quality and sustainability of in vitro diagnostic approaches.

Vianney Souplet, CEO of Innobiochips:

“As part of the Eurasanté healthcare cluster since our foundation, we have a keen interest in contributing to events that promote connections and innovation in healthcare.”

Under the motto “Understanding Life“, the company focuses on diagnostic technologies for better Transplantations and Transfusions, as well as Infectious Diseases and Inflammation diagnostics. These areas of focus are reflected in the company’s three core values: Innovation, Performance and Responsibility.

With years of ISO 13485 certification, various CE-marked solutions developed, and more than 1 million biological tests produced per year, the company continues to demonstrate excellence in the field.

We are very grateful to see them support BioFIT and MedFIT!

Innobiochips, new sponsor of BioFIT and MedFIT 2024 Read More »

Join us for an exclusive pre-BioFIT tour

News / Valentine Delabie

Discover the rich healthtech ecosystem of the Hauts-de-France region

As a BioFIT 2024 participant, we are happy to invite you to join us for a day of discovery of the regional ecosystem, the day before BioFIT.

Discover the richness of our local ecosystem, its key players, networks, initiatives and innovative companies and entrepreneurs.

At the end of the day, a cocktail will be offered at the Eurasanté Hub, brand new building bringing together start-ups, companies, laboratories and plant-school specialising in health innovation.

Eurasanté and Clubster NHL (the competitiveness cluster in health, nutrition and longevity in the Hauts-de-France region) are working to create the ideal programme for this day, which promises to be full of discoveries and networking.

Detailed programme coming soon!

Join us for an exclusive pre-BioFIT tour Read More »

🐾 Discover key Animal Health opportunities at BioFIT 2024

News / Valentine Delabie

Source animal health innovations and make connections at BioFIT 2024

Join us and shape the future of animal health at BioFIT

BioFIT being devoted to fostering early stage innovation deals in Life Sciences, a few years ago the SIMV became a partner of the event and started to organise its R&D Dating for Animal Health and Innovation within BioFIT. Thanks to this collaboration, both human and animal health key players are taking part in the event.
Take a look at the dedicated animal health activities below, including conferences, innovation presentations, and one-on-one meetings.

Discover the Animal Health Highlights track of our conference programme. This dedicated track will provide critical insights into investment trends and the innovative convergence of human and animal health to address the needs of an aging population.

Tuesday, December 3^rd | 2.00 – 2.45 pm
Investors and Animal Health: Expectations and perspectives for 2025

Co-organised by:

Supported by:

Animal health market is influenced by the demand of sustainable products, the ongoing search for more efficiency, safety and quality, as well as the demographically-influenced consumer behaviour towards animal health services. Investors will discuss current animal health investments, their roadmap and how projects can reach their interest.

What is the state of market dynamics regarding animal health investments and how does it impact investors’ perspectives? How can the sector become more appealing to investors? What drives the interest for investment and what are the key points of an attractive project? What criteria do investors prioritise and how can companies reach them? What are the trends implying for 2025 and beyond?

Tuesday, December 3^rd | 3.00 – 3.30 pm
The Ageing of Man and Animal: crafting longer, happier and healthier lives for an ageing population of Pets and People through collaborative translational approaches

Not registered yet?

🐾 Discover key Animal Health opportunities at BioFIT 2024 Read More »

We are proud and thankful to benefit from GENFIT’s continued support!

News / Valentine Delabie

For its 13^th edition, BioFIT is proud to be sponsored by GENFIT, a long-time partner of the event. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases characterised by high unmet medical needs.

Pascal Prigent, CEO of GENFIT commented:

“As a biotechnology company headquartered in the Health Cluster Eurasanté for years, we believe that creating strong connections with our health-innovation ecosystem is essential and mutually beneficial.”

In 2024, GENFIT achieved a historic milestone with the marketing authorization of elafibranor in the US, a “first-in-class” product developed in-house, all the way from discovery to the conclusion of a pivotal Phase III study. The product is now marketed and commercialized in the US by Ipsen under the trademark IQIRVO®.

Today, GENFIT focuses on ACLF, or Acute On-Chronic Liver Failure, a life-threatening condition for which there is currently no therapeutic solution. ACLF presents as a syndrome defined by a cascade of hepatic and extrahepatic organ dysfunctions and failures. In patients with liver cirrhosis and acute hepatic decompensation, ACLF can be triggered by a precipitating event that leads to a progressive functional deterioration of multiple organs with high short-term mortality.

Five different programs are now being conducted with the hope to meet the medical demand for patients in needs.

With such an advancement in their field and an example to follow in terms of innovation in the biotech sector, BioFIT is honoured to be sponsored by GENFIT and will be keen to follow their progress.

We are proud and thankful to benefit from GENFIT’s continued support! Read More »

🤝 Connect and build partnerships with innovators at BioFIT

News / Valentine Delabie

Engage with over 1,000 attendees at BioFIT 2024

Join us to be part of the future of Life Sciences!

Connect with key industry leaders at BioFIT and find your next partner among TTOs, research institutes, academia, big pharma, emerging and small biotechs, diagnostic companies, and pre-seed / seed / series A investors.

They’ll be part of the 2024 cohort of life sciences players:

ABBVIE ADBIO PARTNERS AFSSI ALIATH BIOVENTURES
BOEHRINGER INGELHEIM CAMBON PARTNERS
CAPTECH SANTE CLUSTER SCIENZE DELLA VITA
EFS EUROFINS ADME BIOANALYSES
FOURNIER MAJOIE FOUNDATION FRANCE BIOTECH
GENFIT JAPAN BIOINDUSTRY ASSOCIATION
IPSEN MARUHO DEUTSCHLAND
MEDTECH TWENTE MSD PFIZER ROCHE
SARTORIUS STEDIM BIOTECH SERVIER SIMV
SOFINNOVA PARTNERS SUPERNOVA INVEST SYNGULON
VÉTOQUINOL VIRBAC X’PROCHEM ZOETIS

More reasons to sign up today?

🤝 Maximise networking opportunities: Engage in meaningful conversations during the 3,000+ scheduled meetings. Whether you’re looking for collaborators or investors, BioFIT is the place to be!

🚀 Showcase your innovations: Stand out from 50+ innovators. Pitch your project and attract the attention of key decision makers looking for breakthrough innovations.

💡 Gain insights from thought leaders: Attend our conference programme featuring 60+ international experts sharing their views on the latest trends, challenges and opportunities in the life sciences sector.

🔬 Explore cutting-edge research: Meet with academic researchers and technology transfer officers ready to discuss their latest findings and explore potential partnerships.

📈 Stay ahead of the curve: Discover the latest advances in biotech, pharma and animal health. Learn how to navigate the evolving landscape and stay competitive in the industry.

🤝 Connect and build partnerships with innovators at BioFIT Read More »

Stay informed about the latest advancements in science, laboratory, and research

News / Valentine Delabie

La Gazette du LABORATOIRE is a meeting and exchange point, accessible to all players in the world of Laboratories and Sciences. Created by a scientist for scientists, La Gazette du LABORATOIRE has been supporting the life of French-speaking laboratories in Research, Development, Analysis, and Control since 1995.

Discover our French edition, our Africa edition, and our websites www.gazettelabo.fr and www.LABORATOIRE.com:

Articles and specific content
Resources for your daily work
Practical and technical advice
Professional testimonials, training, job announcements
Information on events related to the field of laboratories and sciences
Tools to communicate about your news, projects, and to increase your notoriety
A search engine dedicated to services and equipment in the field of laboratories and sciences

La Gazette du LABORATOIRE, a human-sized team, at your service – for any questions: contact us! or call us at +33(0)4 77 72 09 65.

Want to join them as a media partner of MedFIT?

Stay informed about the latest advancements in science, laboratory, and research Read More »